Sponsor Pipeline

Intergroupe Francophone du Myelome Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
5
Active Trials
1
Recruiting
2
Phase 3
1
Disease Areas
Active Trials by Phase
Phase 3
2
Not specified
3
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT06918002 Elranatamab/Lenalidomide Consolidation and/or Elranatamab Maintenance Versus Standard of… Multiple Myeloma, Newly Diagnosed Recruiting
NCT04934475 MInimal Residual Disease Adapted Strategy Multiple Myeloma Active, Not Recruiting
Not specified
NCT04144387 Evaluation of the Impact of the Update SMM Criteria on the Natural History of SMM to… Smoldering Multiple Myeloma Active, Not Recruiting
NCT05208086 Diagnostic Performance of Spot Urine Sample for the Monoclonal Components Detection in… Multiple Myeloma Active, Not Recruiting
NCT06062537 Analysis of Effectiveness and Safety of Teclistamab in Relapsed and Refractory Multiple… Multiple Myeloma Active, Not Recruiting
Disease Areas
Multiple Myeloma (5)
Get alerts when Intergroupe Francophone du Myelome's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free